Interpace Biosciences Inc
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2010 | -9.8% | -9.8% | -5.5% |
| FY2011 | -20.0% | -20.0% | -10.5% |
| FY2012 | -71.6% | -71.6% | -32.5% |
| FY2013 | -14.1% | -14.1% | -6.6% |
| FY2014 | -86.3% | -36.0% | -14.6% |
| FY2015 | -135.3% | -78.7% | -21.0% |
| FY2016 | 217.6% | 998.8% | -87.5% |
| FY2017 | 54.8% | 54.8% | 34.3% |
| FY2018 | -82.2% | -82.2% | -40.8% |
| FY2019 | 597.0% | 1,515.0% | -51.9% |
| FY2020 | 91.0% | 104.1% | -57.9% |
| FY2021 | 35.2% | 35.7% | -38.9% |
| FY2022 | 37.8% | 39.0% | -137.4% |
| FY2023 | -3.5% | -3.5% | 14.9% |
| FY2024 | -302.3% | -302.3% | 45.3% |
| FY2025 | 109.9% | 109.9% | 72.6% |